nach oben

Erschienen in:

19.10.2018 | Trigeminusneuralgie | Fortbildung

Fortschritte in Verständnis und Behandlung von Gesichtsschmerzen

Auf dem Weg zur optimierten Therapie der Trigeminusneuralgie

verfasst von: Prof. Dr. med. Mark Obermann

Erschienen in: NeuroTransmitter | Sonderheft 1/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Trigeminusneuralgie (TN) ist nach wie vor eine therapeutische Herausforderung. Die bessere Klassifizierung verschiedener Arten von Gesichtsschmerzen, sowie die Identifizierung von prognostischen Faktoren zur besseren Auswahl der verschiedenen Behandlungsoptionen führen zu einer optimierten Therapie und besseren Lebensqualität für den einzelnen Patienten. Neue Therapieansätze sind derzeit in der klinischen Erprobung, allerdings noch weit entfernt von einer generellen klinischen Einsetzbarkeit. Chirurgische Optionen bleiben eine gute Wahl für Patienten, die nicht auf eine medizinische Behandlung ansprechen.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia Int J Headache 2013;33(9):629–808CrossRef

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia Int J Headache 2018;38(1):1–211CrossRef

De Simone R, Marano E, Brescia Morra V, Ranieri A, Ripa P, Esposito M et al. A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2005;26 Suppl 2:s150–1

Maarbjerg S, Gozalov A, Olesen J, Bendtsen L. Trigeminal neuralgia — a prospective systematic study of clinical characteristics in 158 patients. Headache 2014;54(10):1574–82CrossRef

Szapiro J, Sindou M, Szapiro J. Prognostic factors in microvascular decompression for trigeminal neuralgia. Neurosurgery 1985; 17(6):920–9CrossRef

Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia Int J Headache 2008; 28(2):174–81

Sandell T, Eide PK. Effect of microvascular decompression in trigeminal neuralgia patients with or without constant pain. Neurosurgery 2008;63(1):93–100CrossRef

Hagenacker T, Bude V, Naegel S, Holle D, Katsarava Z, Diener HC et al. Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia. J Headache Pain 2014;15:78CrossRef

Cheshire WP. Trigeminal neuralgia feigns the terrorist. Cephalalgia Int J Headache 2003;23(3):230CrossRef

10.

Tölle T, Dukes E, Sadosky A. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract Off J World Inst Pain 2006;6(3):153–60CrossRef

11.

Symonds T, Randall JA, Hoffman DL, Zakrzewska JM, Gehringer W, Lee JY. Measuring the impact of trigeminal neuralgia pain: the Penn Facial Pain Scale-Revised. J Pain Res 2018;11:1067–73CrossRef

12.

Marinković S, Todorović V, Gibo H, Budec M, Drndarević N, Pesić D et al. The trigeminal vasculature pathology in patients with neuralgia. Headache 2007;47(9):1334–9CrossRef

13.

Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 1980;53(5):674–83CrossRef

14.

Forssell H, Tenovuo O, Silvoniemi P, Jääskeläinen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 2007; 69(14):1451–9CrossRef

15.

Rappaport ZH, Govrin-Lippmann R, Devor M. An electron-microscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact Funct Neurosurg 1997;68(1–4Pt 1):182–6CrossRef

16.

Peker S, Kurtkaya O, Uzün I, Pamir MN. Microanatomy of the central myelin-peripheral myelin transition zone of the trigeminal nerve. Neurosurgery 2006;59(2):354–9CrossRef

17.

Rushton JG, Macdonald HN. Trigeminal neuralgia; special considerations of nonsurgical treatment. J Am Med Assoc 1957;165(5):437–40CrossRef

18.

Herweh C, Kress B, Rasche D, Tronnier V, Tröger J, Sartor K et al. Loss of anisotropy in trigeminal neuralgia revealed by diffusion tensor imaging. Neurology 2007;68(10): 776–8CrossRef

19.

Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. 1967. J Neurosurg. 2007;107(1):216–9CrossRef

20.

Adamczyk M, Bulski T, Sowiñska J, Furmanek A, Bekiesiñska-Figatowska M. Trigeminal nerve-artery contact in people without trigeminal neuralgia — MR study. Med Sci Monit Int Med J Exp Clin Res 2007;13 Suppl 1: 38–43

21.

Kakizawa Y, Seguchi T, Kodama K, Ogiwara T, Sasaki T, Goto T et al. Anatomical study of the trigeminal and facial cranial nerves with the aid of 3.0-tesla magnetic resonance imaging. J Neurosurg 2008;108(3):483–90CrossRef

22.

Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008;71(15):1183–90CrossRef

23.

Hamlyn PJ, King TT. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg 1992; 76(6):948–54CrossRef

24.

Obermann M, Yoon M-S, Ese D, Maschke M, Kaube H, Diener HC et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 2007; 69(9):835–41CrossRef

25.

Gündüz A, Uygunoğlu U, Uluduz D, Saip S, Siva A, Göksan B et al. Reduced inhibition in brainstem circuits in classical trigeminal neuralgia. Eur J Pain 2018; doi: 10.1002/ejp.1293

26.

Borsook D, Moulton EA, Pendse G, Morris S, Cole SH, Aiello-Lammens M et al. Comparison of evoked vs. spontaneous tics in a patient with trigeminal neuralgia (tic doloureux). Mol Pain 2007;3:34PubMedPubMedCentral

27.

Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) - a prospective clinical study of SUNCT and SUNA. Brain J Neurol 2006; 129(Pt 10):2746–60CrossRef

28.

Zebenholzer K, Wöber C, Vigl M, Wessely P, Wöber-Bingöl C. Facial pain and the second edition of the International Classification of Headache Disorders. Headache 2006; 46(2):259–63CrossRef

29.

Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain 2002;18(1):14–21CrossRef

30.

Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008;15(10):1013–28CrossRef

31.

Maarbjerg S, Wolfram F, Gozalov A, Olesen J, Bendtsen L. Significance of neurovascular contact in classical trigeminal neuralgia. Brain J Neurol 2015;138(Pt 2):311–9CrossRef

32.

Heinskou TB, Rochat P, Maarbjerg S, Wolfram F, Brennum J, Olesen J et al. Prognostic factors for outcome of microvascular decompression in trigeminal neuralgia: A prospective systematic study using independent assessors. Cephalalgia Int J Headache 2018; doi: 10.1177/0333102418783294

33.

Wallach J, Ho AL, Kim LH, Chaudhuri AA, Chaudhary N, Vaz-Guimaraes F et al. Quantitative analysis of the safety and efficacy of microvascular decompression for patients with trigeminal neuralgia above and below 65 years of age. J Clin Neurosci 2018;55:13–6CrossRef

34.

Wu A, Doshi T, Hung A, Garzon-Muvdi T, Bender MT, Bettegowda C et al. Immediate and Long-term Outcomes of Microvascular Decompression for Mixed Trigeminal Neuralgia. World Neurosurg 2018;117:e300–e307CrossRef

35.

Zakrzewska JM, Jassim S, Bulman JS. A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the Gasserian ganglion. Pain 1999;79(1):51–8CrossRef

36.

Savica R, Laganà A, Siracusano R, Calabrò RS, Ferlazzo E, Musolino R. Idiopathic familial trigeminal neuralgia: a case report. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2007;28(4):196–8

37.

Smyth P, Greenough G, Stommel E. Familial trigeminal neuralgia: case reports and review of the literature. Headache 2003; 43(8):910–5CrossRef

38.

Cervera-Martinez C, Martinez-Manrique JJ, Revuelta-Gutierrez R. Surgical Management of Familial Trigeminal Neuralgia With Different Inheritance Patterns: A Case Report. Front Neurol 2018; 9:316CrossRef

39.

Keppel Hesselink JM. Moving targets in sodium channel blocker development: the case of raxatrigine: from a central NaV1.3 blocker via a peripheral NaV1.7 blocker to a less selective sodium channel blocker. 2017; J Med Therap 1: DOI: 10.15761/JMT.1000104

40.

Zakrzewska JM, Palmer J, Ettlin DA, Obermann M, Giblin GMP, Morisset V et al. Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia. Trials. 2013;14:402CrossRef

41.

Zakrzewska JM, Palmer J, Morisset V, Giblin GM, Obermann M, Ettlin DA et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 2017;16(4):291–300CrossRef

42.

Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005; 26(5):785–93CrossRef

43.

Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005;65(8):1306–8CrossRef

44.

Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain 2014;15:65CrossRef

45.

Fischoff DK, Spivakovsky S. Botulinum toxin for facial neuralgia. Evid Based Dent 2018;19(2):57–8CrossRef

46.

Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial. Trials 2015;16:550CrossRef

47.

Zakrzewska JM, Jorns TP, Spatz A. Patient led conferences - who attends, are their expectations met and do they vary in three different countries? Eur J Pain 2009; 13(5):486–91CrossRef

48.

Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29(3):265–7CrossRef

49.

Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 1968;19(2):129–36CrossRef

50.

Nicol CF. A four year double-blind study of tegretol in facial pain. Headache 1969; 9(1):54–7CrossRef

51.

Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15(2):129–36CrossRef

52.

Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 2000;20(8 Pt 2):152S–8CrossRef

53.

Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223–30CrossRef

54.

Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984;15(3):240–4CrossRef

55.

Lindström P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987;28(1):45–50CrossRef

56.

Kabatas S, Karasu A, Civelek E, Sabanci AP, Hepgul KT, Teng YD. Microvascular decompression as a surgical management for trigeminal neuralgia: long-term follow-up and review of the literature. Neurosurg Rev 2009;32(1):87–94CrossRef

57.

Little AS, Shetter AG, Shetter ME, Bay C, Rogers CL. Long-term pain response and quality of life in patients with typical trigeminal neuralgia treated with gamma knife stereotactic radiosurgery. Neurosurgery 2008; 63(5):915–24CrossRef

58.

Sindou M, Leston JM, Decullier E, Chapuis F. Microvascular decompression for trigeminal neuralgia: the importance of a noncompressive technique - Kaplan-Meier analysis in a consecutive series of 330 patients. Neurosurgery 2008;63(4 Suppl 2):341–51PubMed

59.

Kanpolat Y, Kahilogullari G, Ugur HC, Elhan AH. Computed tomography-guided percutaneous trigeminal tractotomy-nucleotomy. Neurosurgery 2008;63(1 Suppl 1):ONS147-53; discussion ONS153-5CrossRef

60.

Tatli M, Sindou M. Anatomoradiological landmarks for accuracy of radiofrequency thermorhizotomy in the treatment of trigeminal neuralgia. Neurosurgery 2008;63(1 Suppl 1):ONS129–37; discussion ONS137–8CrossRef

61.

Spatz AL, Zakrzewska JM, Kay EJ. Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 2007;131(3):302–10CrossRef

62.

Yoshimasu F, Kurland LT, Elveback LR. Tic douloureux in Rochester, Minnesota, 1945–1969. Neurology 1972;22(9):952–6CrossRef

63.

Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 1991;10(5–6):276–81CrossRef

64.

MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain J Neurol 2000;123(Pt 4):665–76CrossRef

65.

Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005. BMC Fam Pract 2008;9:26CrossRef

66.

Mueller D, Obermann M, Yoon M-S, Poitz F, Hansen N, Slomke MA et al. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia Int J Headache 2011;31(15): 1542–8CrossRef

67.

Sjaastad O, Bakketeig LS. The rare, unilateral headaches. Vågå study of headache epidemiology. J Headache Pain 2007;8(1):19–27CrossRef

68.

De Simone R, Ranieri A, Bilo L, Fiorillo C, Bonavita V. Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2008;29 Suppl 1:S69–78

Titel: Fortschritte in Verständnis und Behandlung von Gesichtsschmerzen
Auf dem Weg zur optimierten Therapie der Trigeminusneuralgie
verfasst von: Prof. Dr. med. Mark Obermann
Publikationsdatum: 19.10.2018
Verlag: Springer Medizin
Schlagwort: Trigeminusneuralgie
Erschienen in: NeuroTransmitter / Ausgabe Sonderheft 1/2018
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-018-6527-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Auf dem Weg zur optimierten Therapie der Trigeminusneuralgie

Zusammenfassung

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2018

Was wollte der Gesetzgeber und wie haben wir reagiert?

Antikoagulation bei VHF: Vorteile auch im Praxisalltag

Medizinisches Behandlungszentrum für Menschen mit Behinderung

NPPV — Versorgungsmodell in Nordrhein

Evaluation von Neuroedukation

Pathophysiologie, Diagnostik und Behandlungsansätze

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie